Article Text

Download PDFPDF
Should coronavirus policies remain in place to prevent future paediatric influenza deaths?
  1. Dianela Perdomo
  1. Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  1. Correspondence to Dianela Perdomo, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; dperdomo428{at}gmail.com

Abstract

The 2019–2020 to 2020–2021 influenza seasons in the USA saw a dramatic 99.5% decrease in paediatric mortality, with only one influenza death recorded during the latter season. This decrease has been attributed to a substantial reduction in transmission, resulting from the various restrictive measures enacted during the COVID-19 pandemic, onset March 2020. The relative disappearance of influenza raises specific policy questions, such as whether these measures should be kept in place after COVID-19 transmission reaches acceptable levels or herd immunity is achieved. Given the nature of these measures as liberty restricting, it is worth discussing their intended outcome and what values they promote. Do these measures in fact promote health, or simply give the comfort of safety while undermining long-term health and individual liberties? I argue that the year-long endurance of the pandemic well into 2021 may have flattened our value landscape into one where health reigns supreme. Discussions are underway regarding whether we should modify previously accepted health risks, such as the risk of contracting influenza. In this paper, I attempt to clarify the values that motivate our policies and discuss how our present historical context has appreciated the value of health. I also provide an analysis of various pandemic policies and their relation to influenza paediatric deaths. Ultimately, the cost of certain measures on values such as education, socialisation and liberty, among others, is too high to justify their use beyond regulating the spread of COVID-19.

  • policy
  • child
  • COVID-19
  • ethics- medical

Data availability statement

Data sharing is not applicable as no novel datasets were generated through this work. All data analysed and relevant to the research are included in the article and available in public, open access repositories.

This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data sharing is not applicable as no novel datasets were generated through this work. All data analysed and relevant to the research are included in the article and available in public, open access repositories.

View Full Text

Footnotes

  • Contributors DP is the sole guarantor of this work, and author responsible for the planning, conceptualising and writing of the research reported in this manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Other content recommended for you